Evidence map›Paper›PMID 42367437›Full record

ArticleCureus2026

Diplopia and Exophthalmos As Clinical Manifestations of Sinonasal Undifferentiated Carcinoma: A Case Report.

Emily Ha, Ashlyn S Everett

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Emily HaRadiation Oncology, Alabama College of Osteopathic Medicine, Dothan, USA.
Ashlyn S EverettRadiation Oncology, Alliance Cancer Care, Huntsville, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sinonasal undifferentiated carcinoma (SNUC) is a rare and highly aggressive epithelial malignancy with an incidence of 0.2 per 100,000 individuals, often presenting at advanced stages due to nonspecific sinonasal symptoms. Orbital involvement may serve as an important early clinical clue in its diagnosis. A 72-year-old man presented with progressive unilateral exophthalmos, excessive lacrimation, and intermittent diplopia. Imaging revealed an extensive sinonasal mass with orbital involvement. Histopathologic evaluation confirmed the diagnosis of SNUC of the ethmoid sinus, classified according to the American Joint Committee on Cancer 8th edition staging system for sinonasal malignancies as cT4N0M0 (Stage IVA). Due to extensive local invasion with orbital involvement, multidisciplinary consensus favored induction chemotherapy followed by definitive concurrent chemoradiation rather than surgical resection in an effort to preserve orbital function and avoid significant operative morbidity. The patient was treated with induction chemotherapy followed by definitive concurrent chemoradiation, resulting in a complete radiographic and metabolic response. At long-term follow-up, he remains disease-free with manageable treatment-related toxicities. This case highlights the importance of recognizing orbital symptoms as early manifestations of SNUC. It supports the role of induction chemotherapy as part of a multimodal treatment strategy for locally advanced disease.

Indexed as

epithelial cancerethmoid sinus masshematology-oncologyinduction chemotherapyintracranial extensiononcologyradiation oncologysinonasal malignancysinonasal undifferentiated carcinomasnuc

Identifiers

PMID42367437
PMCPMC13310162

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.